HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jill Bargonetti Selected Research

mitosene

7/2010DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jill Bargonetti Research Topics

Disease

26Neoplasms (Cancer)
01/2021 - 10/2002
14Breast Neoplasms (Breast Cancer)
01/2020 - 12/2008
4Triple Negative Breast Neoplasms
06/2021 - 11/2012
2Carcinogenesis
03/2012 - 01/2012
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Colonic Neoplasms (Colon Cancer)
01/2021
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2015
1Neoplasm Metastasis (Metastasis)
01/2014
1Disease Progression
12/2012
1Fanconi Anemia (Fanconi's Anemia)
12/2008
1Necrosis
06/2007

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2012
7DNA (Deoxyribonucleic Acid)IBA
06/2021 - 12/2008
5Protein Isoforms (Isoforms)IBA
01/2020 - 01/2008
5Estrogen ReceptorsIBA
01/2019 - 01/2011
5Estrogens (Estrogen)FDA Link
01/2019 - 01/2008
4ChromatinIBA
01/2017 - 01/2015
3Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2014
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021 - 01/2020
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2020 - 01/2019
2Oncogene Proteins (Oncogene Protein)IBA
08/2019 - 04/2006
2ProteomeIBA
03/2015 - 03/2012
2Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2015 - 12/2008
2Proto-Oncogene Proteins c-mdm2IBA
01/2014 - 03/2012
1olaparibIBA
01/2021
1Radioisotopes (Radionuclides)IBA
01/2021
1Peptides (Polypeptides)IBA
01/2021
1Phenobarbital (Luminal)FDA Link
01/2020
1Monoclonal AntibodiesIBA
02/2019
1AntibodiesIBA
02/2019
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2015
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2015
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2015
1Proliferating Cell Nuclear Antigen (PCNA)IBA
03/2015
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2014
1Glucose (Dextrose)FDA LinkGeneric
12/2012
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2012
1GemcitabineFDA Link
11/2012
1Etoposide (VP 16)FDA LinkGeneric
11/2012
1RNA (Ribonucleic Acid)IBA
03/2012
1Messenger RNA (mRNA)IBA
03/2012
1NucleotidesIBA
03/2012
1Mevalonic Acid (Mevalonate)IBA
01/2012
1SterolsIBA
01/2012
1Estrogen Receptor alphaIBA
01/2011
1Small Interfering RNA (siRNA)IBA
01/2011
1mitoseneIBA
07/2010
1NucleosidesIBA
12/2008
1DeoxyguanosineIBA
12/2008
1Anti-Bacterial Agents (Antibiotics)IBA
12/2008
1nutlin 3IBA
01/2008
1Alkylating AgentsIBA
06/2007
1Biological ProductsIBA
06/2007
1Transcription Factors (Transcription Factor)IBA
04/2006
1Tumor Suppressor Protein p53IBA
07/2005
1Phorbol EstersIBA
03/2004
1Protein Kinase CIBA
03/2004
12,7-diaminomitoseneIBA
10/2002
1DNA AdductsIBA
10/2002

Therapy/Procedure

4Therapeutics
01/2021 - 01/2011
2Drug Therapy (Chemotherapy)
10/2015 - 11/2012
1Precision Medicine
01/2021